25Oct 2021
Oncological benefit of re‐resection for T1 bladder cancer: a comparative effectiveness study

Oncological benefit of re‐resection for T1 bladder cancer: a comparative effectiveness study

To quantify the real‐world survival benefit of re‐resection versus no re‐resection in patients diagnosed with T1 bladder cancer (BC) at the population level. Retrospective population‐wide observational cohort study based on pathology reports linked to health administrative data. We identified patients who were diagnosed with T1 BC in the province of Ontario (01/2001‐12/2015) and used billing claims to ascertain whether they received re‐resection within 2 to 10 weeks. The time‐dependent effect of re‐resection on survival outcomes was modeled by Cox proportional hazards regression (unadjusted and adjusted for numerous assumed patient‐ and surgeon‐level confounding variables). Effect measures were presented as hazard ratios and 95% confidence intervals...

  • #urology

Like

Save

Share